2seventy Bio earnings were -$94.5M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest TSVT earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$9.9M, down 139.9% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, TSVT reported annual earnings of -$217.6M, with -14.4% growth.
On TSVT's earnings call on Invalid Date, 2seventy Bio (NASDAQ: TSVT) reported Q3 2024 earnings per share (EPS) of -$0.19, up 86.43% year over year. Total TSVT earnings for the quarter were -$9.93 million. In the same quarter last year, 2seventy Bio's earnings per share (EPS) was -$1.40.
As of the last 2seventy Bio earnings report, 2seventy Bio is currently losing money. 2seventy Bio's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$94.55 million, a 48.58% decrease year over year.
What was TSVT's earnings growth in the past year?
As of 2seventy Bio's earnings date in Invalid Date, 2seventy Bio's earnings has grown year over year. TSVT earnings in the past year totalled -$94.55 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.